Lagarde raised eyebrows last week by championing a "global euro" as an alternative to the dollar. The greenback's role as a safe-haven for world savings has been rattled this year by the trade, ...

Chris Toomey, a managing director at Morgan Stanley, thinks the market hasn't priced in the risks of the Trump Administration ...

To put it another way, the median 89.5% recovery figure tells us it's very hard to pick winning stocks. Meanwhile, the ...

It turns out that the stocks offering the best returns for investors historically experienced incredibly painful max ...

Crypto US stocks drop as GLXY, MARA, and GME face investor backlash despite bold Bitcoin and AI infrastructure moves.

FactSet estimates see first-quarter earnings of $0.73 per share and revenue of $43.3 billion, up 66 percent from a year ago.

We initiate MS with a Buy rating and $162 PT, as market underestimates durability and scale of earnings rebound underway.

Hinge Health's stock price will be closely watched in its IPO Thursday, after a challenging few years for the health tech ...

Morgan Stanley "stands" by the threat to the economy from the rapid increase in rents in its new report on Greece, ...

As for what stocks to buy, Wilson and the team continue to recommend higher-quality cyclical stocks - well-managed companies with sustainably high, long-term returns and strong balance sheets - as ...

Morgan Stanley points to the 10-year Treasury yield BX:TMUBMUSD10Y. They expect rangebound yields until the last quarter of this year, when the market begins to price in more Fed cuts for 2026 ...

Morgan Stanley's chief market strategist said in an investor note that a stock market decline related to the Moody's ...